In MS, Serious AEs More Common in Rituximab vs Ocrelizumab In MS, Serious AEs More Common in Rituximab vs Ocrelizumab

Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news